YUNIFY Trademark

Trademark Overview

On Wednesday, February 19, 2020, a trademark application was filed for YUNIFY with the United States Patent and Trademark Office. The USPTO has given the YUNIFY trademark a serial number of 88802668. The federal status of this trademark filing is REGISTERED as of Tuesday, March 2, 2021. This trademark is owned by Commave Therapeutics SA. The YUNIFY trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products for the treatment of attention deficit and hyperactivity disorder (ADHD)
yunify

General Information

Serial Number88802668
Word MarkYUNIFY
Filing DateWednesday, February 19, 2020
Status700 - REGISTERED
Status DateTuesday, March 2, 2021
Registration Number6280321
Registration DateTuesday, March 2, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2020

Trademark Statements

Goods and Servicespharmaceutical products for the treatment of attention deficit and hyperactivity disorder (ADHD)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCommave Therapeutics SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGeneva 1202
CH
Party NameCommave Therapeutics SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGeneva 1202
CH
Party NameCommave Therapeutics SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGeneva 1202
CH

Trademark Events

Event DateEvent Description
Saturday, February 22, 2020NEW APPLICATION ENTERED
Monday, February 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 25, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, February 29, 2020ASSIGNED TO LIE
Monday, March 9, 2020PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, May 8, 2020ASSIGNED TO EXAMINER
Monday, May 11, 2020NON-FINAL ACTION WRITTEN
Monday, May 11, 2020NON-FINAL ACTION E-MAILED
Monday, May 11, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 2, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 10, 2020NON-FINAL ACTION WRITTEN
Wednesday, June 10, 2020NON-FINAL ACTION E-MAILED
Wednesday, June 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 30, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 6, 2020NON-FINAL ACTION WRITTEN
Friday, November 6, 2020NON-FINAL ACTION E-MAILED
Friday, November 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 15, 2020PUBLISHED FOR OPPOSITION
Tuesday, December 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 2, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

yunify hyperactivity disorder adhd deficit attention products treatment pharmaceutical